About

**INTELLIGENCE PROFILE: Dr. Mark I. Furman, M.D.** Dr. Mark I. Furman presents a significant intelligence gap for litigation planning, as his credentials, institutional affiliation, and specific medical specialty remain undocumented in available records. This lack of background information is immediately problematic for both hiring decisions and opposition research. His case history shows exclusive involvement in the Vioxx Products Liability Litigation in the Eastern District of Louisiana (2005), appearing twice for plaintiffs in what appears to be the massive MDL consolidation. However, without knowing his medical specialty, board certifications, or academic appointments, it's impossible to assess whether his expertise aligned appropriately with cardiovascular risks, clinical pharmacology, or other relevant Vioxx-related medical issues. Furman's courtroom track record is limited but consistently plaintiff-sided across his documented appearances. The absence of any Daubert challenges in his record could indicate either that his testimony was uncontroversial and well-founded, or more likely, that his involvement was limited in scope or settled before significant motion practice. For plaintiff attorneys, this expert presents substantial strategic risks due to the credential gap—opposing counsel will inevitably exploit any uncertainty about his qualifications, and courts may view undocumented expertise skeptically in a post-Daubert environment. The lack of recent case activity since 2005 raises additional questions about his continued involvement in litigation or current medical practice. Unless comprehensive credential verification can be completed, Furman should be considered a high-risk expert choice, particularly in complex pharmaceutical or medical device litigation where robust academic and clinical credentials are essential for credibility.

Daubert Record 0 on record

No Daubert challenges on record.

Case Appearances from PACER filings